trial · primary record
Senicapoc
Sickle Cell Disease
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 65 |
| Primary completion | 2031-10 |
| Primary endpoint | Hb response rate |
| Registry ID | NCT07282210 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:57.388Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07282210
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.